 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, August 13, 2003, 23(19):7311-7316
Previous Article | Next Article
BRIEF COMMUNICATION
The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation
Haim Einat,1 Peixiong Yuan,1,2 Todd D. Gould,1 Jianling Li,2 JianHua Du,2 Lei Zhang,1 Husseini K. Manji,1 andGuang Chen1 1Laboratory of Molecular Pathophysiology, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, and 2Laboratory of Molecular Pathophysiology, Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan 48201
The neurobiological underpinnings of mood modulation, molecular pathophysiology of manic-depressive illness, and therapeutic mechanism of mood stabilizers are largely unknown. The extracellular signal-regulated kinase (ERK) pathway is activated by neurotrophins and other neuroactive chemicals to produce their effects on neuronal differentiation, survival, regeneration, and structural and functional plasticity. We found that lithium and valproate, commonly used mood stabilizers for the treatment of manic-depressive illness, stimulated the ERK pathway in the rat hippocampus and frontal cortex. Both drugs increased the levels of activated phospho-ERK44/42, activated phospho-ribosomal protein S6 kinase-1 (RSK1) (a substrate of ERK), phospho-CREB (cAMP response element-binding protein) and phospho-B cell lymphoma protein-2 antagonist of cell death (substrates of RSK), and BDNF. Inhibiting the ERK pathway with the blood-brain barrier-penetrating mitogen-activated protein kinase (MAP kinase)/ERK kinase (MEK) kinase inhibitor SL327, but not with the nonblood-brain barrier-penetrating MEK inhibitor U0126, decreased immobility time and increased swimming time of rats in the forced-swim test. SL327, but not U0126, also increased locomotion time and distance traveled in a large open field. The behavioral changes in the open field were prevented with chronic lithium pretreatment. SL327-induced behavioral changes are qualitatively similar to the changes induced by amphetamine, a compound that induces relapse in remitted manic patients and mood elevation in normal subjects. These data suggest that the ERK pathway may mediate the antimanic effects of mood stabilizers.
Key words: mood; affect; bipolar disorder; mania; depression; lithium; valproate; ERK; RSK; CREB; RSK; BAD; BDNF
Received Feb. 4, 2003; revised Jun. 23, 2003; accepted Jun. 23, 2003.
This article has been cited by other articles:
C-W. Tsao, Y-S. Lin, J-T. Cheng, C-F. Lin, H-T. Wu, S-R. Wu, and W-H. Tsai
Interferon-{alpha}-induced serotonin uptake in Jurkat T cells via mitogen-activated protein kinase and transcriptional regulation of the serotonin transporter
J Psychopharmacol, September 1, 2008; 22(7): 753 - 760.
[Abstract] [PDF]
S. Sami, N. Hoti, H.-M. Xu, Z. Shen, and X. Huang
Valproic Acid Inhibits the Growth of Cervical Cancer both In Vitro and In Vivo
J. Biochem., September 1, 2008; 144(3): 357 - 362.
[Abstract] [Full Text] [PDF]
R. C. Padmos, M. H. J. Hillegers, E. M. Knijff, R. Vonk, A. Bouvy, F. J. T. Staal, D. de Ridder, R. W. Kupka, W. A. Nolen, and H. A. Drexhage
A Discriminating Messenger RNA Signature for Bipolar Disorder Formed by an Aberrant Expression of Inflammatory Genes in Monocytes
Arch Gen Psychiatry, April 1, 2008; 65(4): 395 - 407.
[Abstract] [Full Text] [PDF]
Y. Leng, M.-H. Liang, M. Ren, Z. Marinova, P. Leeds, and D.-M. Chuang
Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 Inhibition
J. Neurosci., March 5, 2008; 28(10): 2576 - 2588.
[Abstract] [Full Text] [PDF]
A. A. Kazi and R. D. Koos
Estrogen-Induced Activation of Hypoxia-Inducible Factor-1{alpha}, Vascular Endothelial Growth Factor Expression, and Edema in the Uterus Are Mediated by the Phosphatidylinositol 3-Kinase/Akt Pathway
Endocrinology, May 1, 2007; 148(5): 2363 - 2374.
[Abstract] [Full Text] [PDF]
T. Nagai, K. Takuma, H. Kamei, Y. Ito, N. Nakamichi, D. Ibi, Y. Nakanishi, M. Murai, H. Mizoguchi, T. Nabeshima, et al.
Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex
Learn. Mem., March 2, 2007; 14(3): 117 - 125.
[Abstract] [Full Text] [PDF]
J.-M. Beaulieu, T. D. Sotnikova, R. R. Gainetdinov, and M. G. Caron
Paradoxical Striatal Cellular Signaling Responses to Psychostimulants in Hyperactive Mice
J. Biol. Chem., October 27, 2006; 281(43): 32072 - 32080.
[Abstract] [Full Text] [PDF]
R. Hashimoto, T. Numakawa, T. Ohnishi, E. Kumamaru, Y. Yagasaki, T. Ishimoto, T. Mori, K. Nemoto, N. Adachi, A. Izumi, et al.
Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling
Hum. Mol. Genet., October 15, 2006; 15(20): 3024 - 3033.
[Abstract] [Full Text] [PDF]
H. Einat
Modelling facets of mania - new directions related to the notion of endophenotypes
J Psychopharmacol, September 1, 2006; 20(5): 714 - 722.
[Abstract] [PDF]
J. Brill, M. Lee, S. Zhao, R. D. Fernald, and J. R. Huguenard
Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami.
J. Neurosci., June 21, 2006; 26(25): 6813 - 6822.
[Abstract] [Full Text] [PDF]
F. Fumagalli, A. Frasca, M. Sparta, F. Drago, G. Racagni, and M. A. Riva
Long-Term Exposure to the Atypical Antipsychotic Olanzapine Differently Up-Regulates Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylation in Subcellular Compartments of Rat Prefrontal Cortex
Mol. Pharmacol., April 1, 2006; 69(4): 1366 - 1372.
[Abstract] [Full Text] [PDF]
D. Tardito, J. Perez, E. Tiraboschi, L. Musazzi, G. Racagni, and M. Popoli
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.
Pharmacol. Rev., March 1, 2006; 58(1): 115 - 134.
[Abstract] [Full Text] [PDF]
M. Michaelis, T. Suhan, A. Reinisch, A. Reisenauer, C. Fleckenstein, D. Eikel, H. Gumbel, H. W. Doerr, H. Nau, and J. Cinatl Jr
Increased Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells by Valproic Acid Depends on Histone Deacetylase Inhibition
Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3451 - 3457.
[Abstract] [Full Text] [PDF]
T. D. Gould and H. K. Manji
DARPP-32: A molecular switch at the nexus of reward pathway plasticity
PNAS, January 11, 2005; 102(2): 253 - 254.
[Full Text] [PDF]
J. A. Quiroz, T. D. Gould, and H. K. Manji
MOLECULAR EFFECTS of lithium
Mol. Interv., October 1, 2004; 4(5): 259 - 272.
[Abstract] [Full Text] [PDF]
W. T. O'Brien, A. D. Harper, F. Jove, J. R. Woodgett, S. Maretto, S. Piccolo, and P. S. Klein
Glycogen Synthase Kinase-3{beta} Haploinsufficiency Mimics the Behavioral and Molecular Effects of Lithium
J. Neurosci., July 28, 2004; 24(30): 6791 - 6798.
[Abstract] [Full Text] [PDF]
J. Du, N. A. Gray, C. A. Falke, W. Chen, P. Yuan, S. T. Szabo, H. Einat, and H. K. Manji
Modulation of Synaptic Plasticity by Antimanic Agents: The Role of AMPA Glutamate Receptor Subunit 1 Synaptic Expression
J. Neurosci., July 21, 2004; 24(29): 6578 - 6589.
[Abstract] [Full Text] [PDF]
Y. Hao, T. Creson, L. Zhang, P. Li, F. Du, P. Yuan, T. D. Gould, H. K. Manji, and G. Chen
Mood Stabilizer Valproate Promotes ERK Pathway-Dependent Cortical Neuronal Growth and Neurogenesis
J. Neurosci., July 21, 2004; 24(29): 6590 - 6599.
[Abstract] [Full Text] [PDF]
G. E. Wood, L. T. Young, L. P. Reagan, B. Chen, and B. S. McEwen
Stress-induced structural remodeling in hippocampus: Prevention by lithium treatment
PNAS, March 16, 2004; 101(11): 3973 - 3978.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|